Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Tirzepatide: The weight-loss drug that also shrinks breast tumors in mice Date: July 13, 2025 Source: The Endocrine Society Summary: In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant weight loss in obese mice but also slashed breast cancer tumor growth
An open-label study, involving 20 subjects with painful antiretroviral toxic neuropathy, tested the efficacy of oral ALC at a dose of 2,000 mg/day for a 4-week period
Il margine prefissato saltato
J., Chan, J
Periodic review The guide is updated as services, features, and pricing meaningfully change
US$ 28.14
US$ 24.70
US$ 21.92
US$ 26.58
US$ 21.95
US$ 27.73
